VEGF is a critical cytokine for the growth and survival of cancer cells, and it is well known that inhibition of VEGF function can significantly improve the overall survival of cancer patients (colorectal, lung, glioblastoma, kidney, cervical, and ovarian cancers) [23]. This evidence concerns the gene VEGFA and glioblastoma.